Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

NCT04512105 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
AML, Adult
CLL
CLL, Relapsed
CLL, Refractory

Interventions

DRUG: Pitavastatin
DRUG: Venetoclax

Sponsor

University of California, Irvine

Collaborators

[object Object]